54 related articles for article (PubMed ID: 12075451)
21. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor alpha activates transcription of the NADPH oxidase organizer 1 (NOXO1) gene and upregulates superoxide production in colon epithelial cells.
Kuwano Y; Tominaga K; Kawahara T; Sasaki H; Takeo K; Nishida K; Masuda K; Kawai T; Teshima-Kondo S; Rokutan K
Free Radic Biol Med; 2008 Dec; 45(12):1642-52. PubMed ID: 18929641
[TBL] [Abstract][Full Text] [Related]
23. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation.
Lee CW; Lin WN; Lin CC; Luo SF; Wang JS; Pouyssegur J; Yang CM
J Cell Physiol; 2006 Apr; 207(1):174-86. PubMed ID: 16288471
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation of JNK is involved in regulation of H(+)-induced c-Jun expression.
Shimokawa N; Qiu CH; Seki T; Dikic I; Koibuchi N
Cell Signal; 2004 Jun; 16(6):723-9. PubMed ID: 15093613
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
[TBL] [Abstract][Full Text] [Related]
27. Myocyte enhancer factor 2 mediates vascular inflammation via the p38-dependent pathway.
Suzuki E; Satonaka H; Nishimatsu H; Oba S; Takeda R; Omata M; Fujita T; Nagai R; Hirata Y
Circ Res; 2004 Jul; 95(1):42-9. PubMed ID: 15178640
[TBL] [Abstract][Full Text] [Related]
28. Regulatory role of MEF2D in serum induction of the c-jun promoter.
Han TH; Prywes R
Mol Cell Biol; 1995 Jun; 15(6):2907-15. PubMed ID: 7760790
[TBL] [Abstract][Full Text] [Related]
29. Myocyte enhancer factor 2A is transcriptionally autoregulated.
Ramachandran B; Yu G; Li S; Zhu B; Gulick T
J Biol Chem; 2008 Apr; 283(16):10318-29. PubMed ID: 18073218
[TBL] [Abstract][Full Text] [Related]
30. Global MEF2 target gene analysis in cardiac and skeletal muscle reveals novel regulation of DUSP6 by p38MAPK-MEF2 signaling.
Wales S; Hashemi S; Blais A; McDermott JC
Nucleic Acids Res; 2014 Oct; 42(18):11349-62. PubMed ID: 25217591
[TBL] [Abstract][Full Text] [Related]
31. The molecular characterization and temporal-spatial expression of myocyte enhancer factor 2 genes in the goat and their association with myofiber traits.
Chen L; Cheng B; Li L; Zhan S; Wang L; Zhong T; Chen Y; Zhang H
Gene; 2015 Jan; 555(2):223-30. PubMed ID: 25447896
[TBL] [Abstract][Full Text] [Related]
32. Chromatin Environment and Cellular Context Specify Compensatory Activity of Paralogous MEF2 Transcription Factors.
Majidi SP; Reddy NC; Moore MJ; Chen H; Yamada T; Andzelm MM; Cherry TJ; Hu LS; Greenberg ME; Bonni A
Cell Rep; 2019 Nov; 29(7):2001-2015.e5. PubMed ID: 31722213
[TBL] [Abstract][Full Text] [Related]
33. In Silico Exploration of Conformational Dynamics and Novel Inhibitors for Targeting MEF2-Associated Transcriptional Activity.
Zia A; Imran M; Rashid S
J Chem Inf Model; 2020 Mar; 60(3):1892-1909. PubMed ID: 32031799
[TBL] [Abstract][Full Text] [Related]
34. Myocyte Enhancer Factor 2A Plays a Central Role in the Regulatory Networks of Cellular Physiopathology.
Liu B; Ou WC; Fang L; Tian CW; Xiong Y
Aging Dis; 2023 Apr; 14(2):331-349. PubMed ID: 37008050
[TBL] [Abstract][Full Text] [Related]
35. The MEF2A transcription factor interactome in cardiomyocytes.
Moustafa A; Hashemi S; Brar G; Grigull J; Ng SHS; Williams D; Schmitt-Ulms G; McDermott JC
Cell Death Dis; 2023 Apr; 14(4):240. PubMed ID: 37019881
[TBL] [Abstract][Full Text] [Related]
36. MEF2 and the tumorigenic process, hic sunt leones.
Di Giorgio E; Hancock WW; Brancolini C
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):261-273. PubMed ID: 29879430
[TBL] [Abstract][Full Text] [Related]
37. Aristarchus, Jun. in Explanation.
Aristarchus
Med Phys J; 1802 Apr; 7(38):371-372. PubMed ID: 30490601
[No Abstract] [Full Text] [Related]
38. Signal Transduction in TNF-alpha-induced c-jun Gene Expression.
Zhao M; Liu YW; Liu AH; Zhao KS; Jiang Y
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2000; 32(3):258-264. PubMed ID: 12075451
[TBL] [Abstract][Full Text] [Related]
39. Vascular smooth muscle cell proliferation requires both p38 and BMK1 MAP kinases.
Zhao M; Liu Y; Bao M; Kato Y; Han J; Eaton JW
Arch Biochem Biophys; 2002 Apr; 400(2):199-207. PubMed ID: 12054430
[TBL] [Abstract][Full Text] [Related]
40. Dual roles for MEF2A and MEF2D during human macrophage terminal differentiation and c-Jun expression.
Aude-Garcia C; Collin-Faure V; Bausinger H; Hanau D; Rabilloud T; Lemercier C
Biochem J; 2010 Sep; 430(2):237-44. PubMed ID: 20590529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
